Hosszu, Laszlo L. P. http://orcid.org/0000-0003-1625-6329
Conners, Rebecca
Sangar, Daljit
Batchelor, Mark http://orcid.org/0000-0001-6847-5131
Sawyer, Elizabeth B. http://orcid.org/0000-0003-0389-2692
Fisher, Stuart
Cliff, Matthew J. http://orcid.org/0000-0002-7482-0234
Hounslow, Andrea M.
McAuley, Katherine
Leo Brady, R. http://orcid.org/0000-0002-3575-5513
Jackson, Graham S.
Bieschke, Jan
Waltho, Jonathan P. http://orcid.org/0000-0002-7402-5492
Collinge, John http://orcid.org/0000-0003-2220-7566
Article History
Received: 23 October 2019
Accepted: 3 July 2020
First Online: 29 July 2020
Competing interests
: G.S.J. and J.C. are shareholders, and J.C. a director of D-Gen Limited, an academic spin-out company in the field of prion disease diagnosis, decontamination, and therapeutics, which provided the ICSM18 monoclonal antibody used in this study. The remaining authors share no competing interests.